{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:23:01Z","timestamp":1787062981429,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical research, Government of India","doi-asserted-by":"crossref","award":["ICMR-JRF, 3\/1\/3\/JRF-2009\/MPD 31381"],"award-info":[{"award-number":["ICMR-JRF, 3\/1\/3\/JRF-2009\/MPD 31381"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sanjay Gandhi Post Graduate medical Sciences, Lucknow, India","award":["Intramural grant (39:287)"],"award-info":[{"award-number":["Intramural grant (39:287)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s12017-015-8364-8","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T06:29:35Z","timestamp":1438151375000},"page":"364-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Role of Oxidative Stress in the Worsening of Neurologic Wilson Disease Following Chelating Therapy"],"prefix":"10.1007","volume":"17","author":[{"given":"Jayantee","family":"Kalita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha K.","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"issue":"2","key":"8364_CR1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.trsl.2009.05.002","volume":"154","author":"GJ Brewer","year":"2009","unstructured":"Brewer, G. J., Askari, F., Dick, R. B., Sitterly, J., Fink, J. K., Carlson, M., et al. (2009). Treatment of Wilson\u2019s disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine. Translational Research, 154(2), 70\u201377. doi: 10.1016\/j.trsl.2009.05.002 .","journal-title":"Translational Research"},{"issue":"4","key":"8364_CR2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archneur.63.4.521","volume":"63","author":"GJ Brewer","year":"2006","unstructured":"Brewer, G. J., Askari, F., Lorincz, M. T., Carlson, M., Schilsky, M., Kluin, K. J., et al. (2006). Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Archives of Neurology, 63(4), 521\u2013527. doi: 10.1001\/archneur.63.4.521 .","journal-title":"Archives of Neurology"},{"issue":"3","key":"8364_CR3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-2008-1040842","volume":"19","author":"GJ Brewer","year":"1999","unstructured":"Brewer, G. J., Fink, J. K., & Hedera, P. (1999). Diagnosis and treatment of Wilson\u2019s disease. Seminars in Neurology, 19(3), 261\u2013270. doi: 10.1055\/s-2008-1040842 .","journal-title":"Seminars in Neurology"},{"issue":"3","key":"8364_CR4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneur.60.3.379","volume":"60","author":"GJ Brewer","year":"2003","unstructured":"Brewer, G. J., Hedera, P., Kluin, K. J., Carlson, M., Askari, F., Dick, R. B., et al. (2003). Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Archives of Neurology, 60(3), 379\u2013385.","journal-title":"Archives of Neurology"},{"issue":"5","key":"8364_CR5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.1987.00520170020016","volume":"44","author":"GJ Brewer","year":"1987","unstructured":"Brewer, G. J., Terry, C. A., Aisen, A. M., & Hill, G. M. (1987). Worsening of neurologic syndrome in patients with Wilson\u2019s disease with initial penicillamine therapy. Archives of Neurology, 44(5), 490\u2013493.","journal-title":"Archives of Neurology"},{"issue":"11","key":"8364_CR6","first-page":"544","volume":"148","author":"R Bruha","year":"2009","unstructured":"Bruha, R., Marecek, Z., Martasek, P., Nevsimalova, S., Petrtyl, J., Urbanek, P., et al. (2009). Wilson\u2019s disease. Cas Lek Cesk, 148(11), 544\u2013548.","journal-title":"Cas Lek Cesk"},{"issue":"1","key":"8364_CR7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1478-3231.2010.02354.x","volume":"31","author":"R Bruha","year":"2011","unstructured":"Bruha, R., Marecek, Z., Pospisilova, L., Nevsimalova, S., Vitek, L., Martasek, P., et al. (2011). Long-term follow-up of Wilson disease: Natural history, treatment, mutations analysis and phenotypic correlation. Liver International, 31(1), 83\u201391. doi: 10.1111\/j.1478-3231.2010.02354.x .","journal-title":"Liver International"},{"issue":"3","key":"8364_CR8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10545-011-9422-5","volume":"35","author":"R Bruha","year":"2012","unstructured":"Bruha, R., Vitek, L., Marecek, Z., Pospisilova, L., Nevsimalova, S., Martasek, P., et al. (2012). Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms. Journal of Inherited Metabolic Disease, 35(3), 541\u2013548. doi: 10.1007\/s10545-011-9422-5 .","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"4","key":"8364_CR9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ng1293-327","volume":"5","author":"PC Bull","year":"1993","unstructured":"Bull, P. C., Thomas, G. R., Rommens, J. M., Forbes, J. R., & Cox, D. W. (1993). The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nature Genetics, 5(4), 327\u2013337. doi: 10.1038\/ng1293-327 .","journal-title":"Nature Genetics"},{"issue":"5","key":"8364_CR10","doi-asserted-by":"crossref","first-page":"e37709","DOI":"10.1371\/journal.pone.0037709","volume":"7","author":"DB Chen","year":"2012","unstructured":"Chen, D. B., Feng, L., Lin, X. P., Zhang, W., Li, F. R., Liang, X. L., et al. (2012). Penicillamine increases free copper and enhances oxidative stress in the brain of toxic milk mice. PLoS One, 7(5), e37709. doi: 10.1371\/journal.pone.0037709 .","journal-title":"PLoS One"},{"issue":"6","key":"8364_CR11","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1046\/j.1471-4159.2001.00374.x","volume":"77","author":"Y Chen","year":"2001","unstructured":"Chen, Y., Vartiainen, N. E., Ying, W., Chan, P. H., Koistinaho, J., & Swanson, R. A. (2001). Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. Journal of Neurochemistry, 77(6), 1601\u20131610.","journal-title":"Journal of Neurochemistry"},{"key":"8364_CR12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2008.10.056","volume":"1248","author":"BS Choi","year":"2009","unstructured":"Choi, B. S., & Zheng, W. (2009). Copper transport to the brain by the blood-brain barrier and blood-CSF barrier. Brain Research, 1248, 14\u201321. doi: 10.1016\/j.brainres.2008.10.056 .","journal-title":"Brain Research"},{"issue":"18","key":"8364_CR13","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.1993.03500180078038","volume":"269","author":"RM Crum","year":"1993","unstructured":"Crum, R. M., Anthony, J. C., Bassett, S. S., & Folstein, M. F. (1993). Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA, 269(18), 2386\u20132391.","journal-title":"JAMA"},{"issue":"9","key":"8364_CR14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ncpneuro0291","volume":"2","author":"SK Das","year":"2006","unstructured":"Das, S. K., & Ray, K. (2006). Wilson\u2019s disease: An update. Nature Clinical Practice Neurology, 2(9), 482\u2013493. doi: 10.1038\/ncpneuro0291 .","journal-title":"Nature Clinical Practice Neurology"},{"issue":"8","key":"8364_CR15","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1523\/JNEUROSCI.16-08-02553.1996","volume":"16","author":"S Desagher","year":"1996","unstructured":"Desagher, S., Glowinski, J., & Premont, J. (1996). Astrocytes protect neurons from hydrogen peroxide toxicity. Journal of Neuroscience, 16(8), 2553\u20132562.","journal-title":"Journal of Neuroscience"},{"key":"8364_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fnagi.2013.00009","volume":"5","author":"R Dringen","year":"2013","unstructured":"Dringen, R., Scheiber, I. F., & Mercer, J. F. (2013). Copper metabolism of astrocytes. Frontiers in Aging Neuroscience, 5, 9. doi: 10.3389\/fnagi.2013.00009 .","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1\u20132","key":"8364_CR17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0300-483X(03)00159-8","volume":"189","author":"LM Gaetke","year":"2003","unstructured":"Gaetke, L. M., & Chow, C. K. (2003). Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology, 189(1\u20132), 147\u2013163.","journal-title":"Toxicology"},{"issue":"2 (Pt 1)","key":"8364_CR18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/WNL.41.2_Part_1.272","volume":"41","author":"G Grimm","year":"1991","unstructured":"Grimm, G., Prayer, L., Oder, W., Ferenci, P., Madl, C., Knoflach, P., et al. (1991). Comparison of functional and structural brain disturbances in Wilson\u2019s disease. Neurology, 41(2 (Pt 1)), 272\u2013276.","journal-title":"Neurology"},{"issue":"1","key":"8364_CR19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10534-014-9706-y","volume":"27","author":"G Gromadzka","year":"2014","unstructured":"Gromadzka, G., Karpinska, A., Przybylkowski, A., Litwin, T., Wierzchowska-Ciok, A., Dziezyc, K., et al. (2014). Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease. BioMetals, 27(1), 207\u2013215. doi: 10.1007\/s10534-013-9694-3 .","journal-title":"BioMetals"},{"issue":"9","key":"8364_CR20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","volume":"18","author":"B Halliwell","year":"2001","unstructured":"Halliwell, B. (2001). Role of free radicals in the neurodegenerative diseases: Therapeutic implications for antioxidant treatment. Drugs and Aging, 18(9), 685\u2013716.","journal-title":"Drugs and Aging"},{"issue":"6","key":"8364_CR21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0891-5849(90)90131-2","volume":"9","author":"DR Janero","year":"1990","unstructured":"Janero, D. R. (1990). Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biology and Medicine, 9(6), 515\u2013540.","journal-title":"Free Radical Biology and Medicine"},{"issue":"5","key":"8364_CR22","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/hep.22792","volume":"49","author":"B Joseph","year":"2009","unstructured":"Joseph, B., Kapoor, S., Schilsky, M. L., & Gupta, S. (2009). Bile salt-induced pro-oxidant liver damage promotes transplanted cell proliferation for correcting Wilson disease in the Long-Evans Cinnamon rat model. Hepatology, 49(5), 1616\u20131624. doi: 10.1002\/hep.22792 .","journal-title":"Hepatology"},{"issue":"3\u20134","key":"8364_CR23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000355276","volume":"71","author":"J Kalita","year":"2014","unstructured":"Kalita, J., Kumar, V., Chandra, S., Kumar, B., & Misra, U. K. (2014a). Worsening of Wilson disease following penicillamine therapy. European Neurology, 71(3\u20134), 126\u2013131. doi: 10.1159\/000355276 .","journal-title":"European Neurology"},{"issue":"1\u20132","key":"8364_CR24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneuroim.2014.06.013","volume":"274","author":"J Kalita","year":"2014","unstructured":"Kalita, J., Kumar, V., Misra, U. K., Ranjan, A., Khan, H., & Konwar, R. (2014b). A study of oxidative stress, cytokines and glutamate in Wilson disease and their asymptomatic siblings. Journal of Neuroimmunology, 274(1\u20132), 141\u2013148. doi: 10.1016\/j.jneuroim.2014.06.013 .","journal-title":"Journal of Neuroimmunology"},{"issue":"4","key":"8364_CR25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4103\/0028-3886.68678","volume":"58","author":"J Kalita","year":"2010","unstructured":"Kalita, J., Somarajan, B. I., Misra, U. K., & Mittal, B. (2010). R778L, H1069Q, and I1102T mutation study in neurologic Wilson disease. Neurology India, 58(4), 627\u2013630. doi: 10.4103\/0028-3886.68678 .","journal-title":"Neurology India"},{"issue":"5","key":"8364_CR26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/jcp.54.5.356","volume":"54","author":"D Koracevic","year":"2001","unstructured":"Koracevic, D., Koracevic, G., Djordjevic, V., Andrejevic, S., & Cosic, V. (2001). Method for the measurement of antioxidant activity in human fluids. Journal of Clinical Pathology, 54(5), 356\u2013361.","journal-title":"Journal of Clinical Pathology"},{"issue":"5","key":"8364_CR27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.21392","volume":"22","author":"P Krystkowiak","year":"2007","unstructured":"Krystkowiak, P., du Montcel, S. T., Vercueil, L., Houeto, J. L., Lagrange, C., Cornu, P., et al. (2007). Reliability of the Burke\u2013Fahn\u2013Marsden scale in a multicenter trial for dystonia. Movement Disorders, 22(5), 685\u2013689. doi: 10.1002\/mds.21392 .","journal-title":"Movement Disorders"},{"issue":"1","key":"8364_CR28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1471-4159.1994.62010045.x","volume":"62","author":"TK Makar","year":"1994","unstructured":"Makar, T. K., Nedergaard, M., Preuss, A., Gelbard, A. S., Perumal, A. S., & Cooper, A. J. (1994). Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: Evidence that astrocytes play an important role in antioxidative processes in the brain. Journal of Neurochemistry, 62(1), 45\u201353.","journal-title":"Journal of Neurochemistry"},{"issue":"4","key":"8364_CR29","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1006\/bbrc.2001.5259","volume":"285","author":"MD Mattie","year":"2001","unstructured":"Mattie, M. D., & Freedman, J. H. (2001). Protective effects of aspirin and vitamin E (alpha-tocopherol) against copper- and cadmium-induced toxicity. Biochemical and Biophysics Research Communications, 285(4), 921\u2013925. doi: 10.1006\/bbrc.2001.5259 .","journal-title":"Biochemical and Biophysics Research Communications"},{"issue":"4","key":"8364_CR30","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1203\/01.pdr.0000238341.12229.d3","volume":"60","author":"H Nagasaka","year":"2006","unstructured":"Nagasaka, H., Inoue, I., Inui, A., Komatsu, H., Sogo, T., Murayama, K., et al. (2006). Relationship between oxidative stress and antioxidant systems in the liver of patients with Wilson disease: Hepatic manifestation in Wilson disease as a consequence of augmented oxidative stress. Pediatric Research, 60(4), 472\u2013477. doi: 10.1203\/01.pdr.0000238341.12229.d3 .","journal-title":"Pediatric Research"},{"issue":"1","key":"8364_CR31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12011-008-8219-3","volume":"127","author":"D Ozcelik","year":"2009","unstructured":"Ozcelik, D., & Uzun, H. (2009). Copper intoxication; antioxidant defenses and oxidative damage in rat brain. Biological Trace Element Research, 127(1), 45\u201352. doi: 10.1007\/s12011-008-8219-3 .","journal-title":"Biological Trace Element Research"},{"key":"8364_CR32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neuro.2015.05.004","volume":"49","author":"A Ranjan","year":"2015","unstructured":"Ranjan, A., Kalita, J., Kumar, V., & Misra, U. K. (2015). MRI and oxidative stress markers in neurological worsening of Wilson disease following penicillamine. Neurotoxicology, 49, 45\u201349. doi: 10.1016\/j.neuro.2015.05.004 .","journal-title":"Neurotoxicology"},{"issue":"8","key":"8364_CR33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/labinvest.2008.49","volume":"88","author":"PV Reddy","year":"2008","unstructured":"Reddy, P. V., Rao, K. V., & Norenberg, M. D. (2008). The mitochondrial permeability transition, and oxidative and nitrosative stress in the mechanism of copper toxicity in cultured neurons and astrocytes. Laboratory Investigation, 88(8), 816\u2013830. doi: 10.1038\/labinvest.2008.49 .","journal-title":"Laboratory Investigation"},{"issue":"7","key":"8364_CR34","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.freeradbiomed.2011.06.027","volume":"51","author":"TT Reed","year":"2011","unstructured":"Reed, T. T. (2011). Lipid peroxidation and neurodegenerative disease. Free Radical Biology and Medicine, 51(7), 1302\u20131319. doi: 10.1016\/j.freeradbiomed.2011.06.027 .","journal-title":"Free Radical Biology and Medicine"},{"issue":"6","key":"8364_CR35","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/hep.22261","volume":"47","author":"EA Roberts","year":"2008","unstructured":"Roberts, E. A., Schilsky, M. L., & American Association for Study of Liver, D. (2008). Diagnosis and treatment of Wilson disease: An update. Hepatology, 47(6), 2089\u20132111. doi: 10.1002\/hep.22261 .","journal-title":"Hepatology"},{"issue":"3","key":"8364_CR36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbadis.2005.06.004","volume":"1741","author":"A Samuele","year":"2005","unstructured":"Samuele, A., Mangiagalli, A., Armentero, M. T., Fancellu, R., Bazzini, E., Vairetti, M., et al. (2005). Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson\u2019s disease. Biochimica et Biophysica Acta, 1741(3), 325\u2013330. doi: 10.1016\/j.bbadis.2005.06.004 .","journal-title":"Biochimica et Biophysica Acta"},{"issue":"5","key":"8364_CR37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neuint.2012.08.017","volume":"62","author":"IF Scheiber","year":"2013","unstructured":"Scheiber, I. F., & Dringen, R. (2013). Astrocyte functions in the copper homeostasis of the brain. Neurochemistry International, 62(5), 556\u2013565. doi: 10.1016\/j.neuint.2012.08.017 .","journal-title":"Neurochemistry International"},{"issue":"12","key":"8364_CR38","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/clinchem\/20.12.1556","volume":"20","author":"KH Schosinsky","year":"1974","unstructured":"Schosinsky, K. H., Lehmann, H. P., & Beeler, M. F. (1974). Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clinical Chemistry, 20(12), 1556\u20131563.","journal-title":"Clinical Chemistry"},{"issue":"6","key":"8364_CR39","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/0016-5085(94)90822-2","volume":"107","author":"RJ Sokol","year":"1994","unstructured":"Sokol, R. J., Twedt, D., McKim, J. M, Jr, Devereaux, M. W., Karrer, F. M., Kam, I., et al. (1994). Oxidant injury to hepatic mitochondria in patients with Wilson\u2019s disease and Bedlington terriers with copper toxicosis. Gastroenterology, 107(6), 1788\u20131798.","journal-title":"Gastroenterology"},{"issue":"1\u20133","key":"8364_CR40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0300-483X(94)90168-6","volume":"92","author":"OM Steinebach","year":"1994","unstructured":"Steinebach, O. M., & Wolterbeek, H. T. (1994). Role of cytosolic copper, metallothionein and glutathione in copper toxicity in rat hepatoma tissue culture cells. Toxicology, 92(1\u20133), 75\u201390.","journal-title":"Toxicology"},{"issue":"3","key":"8364_CR41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s007020050026","volume":"107","author":"HJ Stuerenburg","year":"2000","unstructured":"Stuerenburg, H. J. (2000). CSF copper concentrations, blood\u2013brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson\u2019s disease. J Neural Transm, 107(3), 321\u2013329.","journal-title":"J Neural Transm"},{"issue":"1","key":"8364_CR42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0006-2944(85)90067-5","volume":"34","author":"KH Summer","year":"1985","unstructured":"Summer, K. H., & Eisenburg, J. (1985). Low content of hepatic reduced glutathione in patients with Wilson\u2019s disease. Biochemical Medicine, 34(1), 107\u2013111.","journal-title":"Biochemical Medicine"},{"issue":"2","key":"8364_CR43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ng0295-210","volume":"9","author":"GR Thomas","year":"1995","unstructured":"Thomas, G. R., Forbes, J. R., Roberts, E. A., Walshe, J. M., & Cox, D. W. (1995). The Wilson disease gene: Spectrum of mutations and their consequences. Nature Genetics, 9(2), 210\u2013217. doi: 10.1038\/ng0295-210 .","journal-title":"Nature Genetics"},{"issue":"3","key":"8364_CR44","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0003-2697(69)90064-5","volume":"27","author":"F Tietze","year":"1969","unstructured":"Tietze, F. (1969). Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Analytical Biochemistry, 27(3), 502\u2013522.","journal-title":"Analytical Biochemistry"},{"issue":"1","key":"8364_CR45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbrc.2015.01.071","volume":"458","author":"JW Zhang","year":"2015","unstructured":"Zhang, J. W., Liu, J. X., Hou, H. M., Chen, D. B., Feng, L., Wu, C., et al. (2015). Effects of tetrathiomolybdate and penicillamine on brain hydroxyl radical and free copper levels: A microdialysis study in vivo. Biochemical and Biophysics Research Communications, 458(1), 82\u201385. doi: 10.1016\/j.bbrc.2015.01.071 .","journal-title":"Biochemical and Biophysics Research Communications"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-015-8364-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-015-8364-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-015-8364-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T12:24:48Z","timestamp":1599395088000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-015-8364-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["8364"],"URL":"https:\/\/doi.org\/10.1007\/s12017-015-8364-8","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]}}}